RGNX REGENXBIO Inc.companySEC Filings & Insider Trading Activity 2026
Latest REGENXBIO Inc. (RGNX) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 5, 2026, a 10-Q quarterly report filed on May 14, 2026, an 8-K current report filed on July 20, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for REGENXBIO Inc. (RGNX) (SEC CIK 1590877), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on REGENXBIO Inc.
Ask AI about RGNX filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting RGNX positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on RGNX.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of REGENXBIO Inc. (RGNX) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 20, 2026 | - | - | - |
8-K | Jun 29, 2026 | - | - | - |
8-K | Jun 3, 2026 | - | - | |
10-Q | May 14, 2026 | Mar 31, 2026 | - | |
8-K | May 14, 2026 | - | - | |
8-K | Mar 20, 2026 | - | - | - |
8-K | Mar 5, 2026 | - | Analysis | - |
10-K | Mar 5, 2026 | Dec 31, 2025 | - | |
8-K | Feb 10, 2026 | - | - | |
8-K | Jan 28, 2026 | - | - | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | - | |
10-Q | May 12, 2025 | Mar 31, 2025 | - | |
10-K | Mar 13, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 6, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 1, 2024 | Jun 30, 2024 | - | |
10-Q | May 8, 2024 | Mar 31, 2024 | - | |
10-K | Feb 27, 2024 | Dec 31, 2023 | - | |
SC 13G | Nov 17, 2023 | - | - | |
10-Q | Nov 8, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 2, 2023 | Jun 30, 2023 | - | |
10-Q | May 3, 2023 | Mar 31, 2023 | - | |
SC 13G | Apr 7, 2023 | - | - | |
10-K | Feb 28, 2023 | Dec 31, 2022 | - | |
10-Q | Nov 3, 2022 | Sep 30, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate RGNX share value held by 13F filers tracked by SignalX, by quarter.
- State Street Corp+444.7K (+19%)
- Two Sigma Investments+425.0K (+327%)
- D.E. Shaw & Co+217.6K (+318%)
- Citigroup+115.4K (+1246%)
- Dimensional Fund Advisors+106.5K (+12%)
- AQR Capital Management310.3K (-23%)
- Ameriprise Financial47.0K (-19%)
- Citadel Advisors LLC42.7K (-53%)
- Wells Fargo & Co34.6K (-41%)
- Renaissance Technologies LLC27.8K (-8%)
- Franklin Resources+16.8K
- Prudential Financial+12.4K
- JPMorgan Chase & Co−3.55M
- Vanguard Group Inc−3.37M
- Invesco Ltd−157.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 171 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest RGNX SEC filings in 2026?
REGENXBIO Inc. (RGNX) has filed a 10-K annual report on March 5, 2026, a 10-Q quarterly report on May 14, 2026, an 8-K current report on July 20, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did RGNX file its most recent 10-K annual report?
REGENXBIO Inc. (RGNX) filed its most recent 10-K annual report on March 5, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view RGNX 10-Q quarterly reports?
REGENXBIO Inc. (RGNX)'s most recent 10-Q quarterly report was filed on May 14, 2026. SignalX displays every RGNX 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has RGNX filed recently?
REGENXBIO Inc. (RGNX)'s most recent 8-K was filed on July 20, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find RGNX insider trading activity (Form 4)?
SignalX aggregates every RGNX Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does RGNX file with the SEC?
REGENXBIO Inc. (RGNX) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new RGNX filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for REGENXBIO Inc. (RGNX).
What is RGNX's SEC CIK number?
REGENXBIO Inc. (RGNX)'s SEC CIK (Central Index Key) number is 1590877. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1590877 to look up all RGNX filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of REGENXBIO Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 68+ filings.